Komori
Mochida Pharmaceutical (4534) · InitiativeRestated

Supply Chain Management through Sustainable Procurement

First written in FY2023. 2 of 4 entries say "Advanced", first in FY2024. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024 – FY20252023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Supply Chain Sustainability ManagementA theme 158 companies write about · 6 as a headwind · 163 as a tailwind

18 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 158 companies compared. The sentences above are computed from all 158.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「We will provide business partners who responded with aggregated results for each question and encourage improvements by enabling them to assess their relative level. By working collaboratively on identified issues, we will promote sustainable procurement together with our suppliers.」

    The company continues its policy of promoting sustainable procurement through feedback on supplier survey results and collaborative improvements.
  2. FY2025AdvancedAnnual report

    「The survey response rate was approximately 90%. Variations were identified in the status of initiatives, including the establishment of systems, particularly in the areas of the environment, corporate governance and fair business practices.」

    The response rate for the supplier survey in fiscal 2024 was approximately 90%, and the company stated a policy of providing feedback on the results and moving toward collaborative improvements.
  3. FY2024AdvancedAnnual report

    「The survey response rate was approximately 80%. Variations were identified in the status of initiatives, particularly in the areas of the environment and corporate governance.」

    In fiscal 2023, the company conducted a sustainability survey of suppliers and received responses from approximately 80%. It stated a policy of providing feedback to business partners and encouraging improvements through collaboration.
  4. FY2023First statedAnnual report

    「Our group has established Sustainable Procurement Guidelines setting out the matters it expects business partners to address, based on its Sustainable Procurement Policy, which was established to fulfil corporate social responsibility across the entire supply chain, including business partners. We will also proceed with surveys and other checks of business partners' sustainability initiatives.」

    The company has, for the first time, described the Sustainable Procurement Policy, guidelines for business partners and surveys to monitor the status of related initiatives as standalone supply chain measures.
Moved together

"Partnerships that connect internal and external resources" moved the same way as this thread, in the same document, in 2 of its 4 moves.

222222★123456
  1. ★This thread
  2. 1Partnerships that connect internal and external resources2×
  3. 2Lifecycle Management and Strategic Alliances2×
  4. 3Overseas Expansion of Proprietary Products and the Biomaterials Business2×
  5. 4Progress in Regulatory Approvals, Applications, and Clinical Development2×
  6. 5Strengthening the Development Pipeline through Open Innovation2×
  7. 6Expansion of the Dermatology-Based Skincare Business2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Supply Chain Management through Sustainable Procurement | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori